22 results on '"C. Venegoni"'
Search Results
2. Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence
- Author
-
L. Martinez-Vidal, M. Chighizola, M. Berardi, E. Alchera, I. Locatelli, F. Pederzoli, C. Venegoni, R. Lucianò, P. Milani, K. Bielawski, A. Salonia, A. Podestà, M. Alfano
- Published
- 2023
- Full Text
- View/download PDF
3. [Efficacy of and tolerance to a new NSAID in the treatment of arthrosis: droxicam. Randomized study versus tenoxicam]
- Author
-
M, Chevallard, C, Venegoni, and B, Colombo
- Subjects
Adult ,Male ,Piroxicam ,Pyridines ,Anti-Inflammatory Agents, Non-Steroidal ,Osteoarthritis ,Humans ,Female ,Middle Aged ,Aged - Abstract
A four-week open study was carried out to evaluate the efficacy and tolerability of droxicam, a new NSAID, in the treatment of painful osteoarthritis (OA). The results were compared with those obtained treating a similar group of patients with tenoxicam, at the same dosage of 20 mg/day, orally administered. The study showed that both drugs are effective in treating OA, with a mild predominance of droxicam in decreasing pain, functional limitation and chronic inability score. Tolerability was excellent or good in over 70% of patients and only one subject of each group was dropped out for severe side-effects. According to the Authors droxicam has shown to be an effective analgesic and anti-inflammatory agent as judged by its efficacy on pain relief and joint mobility in OA.
- Published
- 1993
4. Mediterranean Symposium of rheumatology
- Author
-
L. Schiavetti, M. Galeazzi, M. Purpura, M. Pras, D. Zemer, S. Cabili, A. Ciocci, B. Colombo, S. Tosi, E. Govoni, G. Genacchi, U. Carcassi, Q. Mela, L. Bonomo, F. Aiuti, R. D'Amelio, J. M. Puigdollers-Colas, N. Roca-Rossellini, J. Permanyer-Barrier, M. A. Puigdollers Rovellat, A. E. Georgiadis, H. Yazici, Y. Tuzun, S. Yurdakul, H. Pazarli, Y. Ozyazgan, H. Ozdogan, S. Serdarogu, M. Ersanli, B. Ulku, A. Muftuoglu, N. Dilsen, M. Konice, O. Aral, M. Giordano, L. Cotticelli, S. Migliaresi, U. Picillo, G. Tirri, M. Hamza, M. L. Ciompi, P. V. Fosella, P. Ammannati, G. Gremignal, I. Olivieri, S. Tassoni, F. Pecori, M. Gamici, A. Porciatt, F. Fantini, F. Valenti, F. Marin, F. Mercuriali, J. Figueirinhas, V. Silva, R. Tanakol, J. Pecar, V. Daneo, V. Modena, I. Maiocco, C. Bosio, P. G. De Filipi, A. A. Drosos, H. M. Moutsopoulos, P. Oriente, R. Scarpa, A. Pucino, C. Biondi-Oriente, P. Jacquot, M. Blanc, D. Giordano, Y. Pennec, P. Youinou, D. Mottier, J. Jouquan, A. Gentric, C. Ferec, G. Le Menn, U. Ambamelli, A. Kontomerkos, N. Karagiannidis, A. Georgiadis, P. Dantis, G. Dilsen, G. Rovetta, C. Cervini, T. Hadidi, G. Valentini, U. Chianese, L. Gualdieri, A. Maniera, R. Tirri, F. La Palombara, A. K. Mavridis, G. Serratrice, A. Schiano, C. Desnuelles, J. Pouget, A. Zoppini, E. Taccari, S. Teddori, H. Roux, G. M. Antipoff, D. Paris, J. Thivolet, C. Hermier, F. Fabiano, M. Bevilacqua, R. Ramonda, P. Lazzarin, P. A. Ostuni, S. Todesco, S. H. Contantopoulos, L. Capelli, M. Vatti, G. Fichera, J. Sany, B. Combes, B. Cosso, M. Bonneaux, M. Andary, J. Clot, G. Consoli, L. Di Mattteo, W. Wirth, G. Lonauer, F. Demptroeder, L. Sinigaglia, G. Guidi, R. Ranza, A. Marchesoni, M. M. Abdelkafi, T. Medeb, M. T. Kassab, M. Cammoun, H. Jaafoura, R. Hamza, B. Ben Lamine, G. Traballi, A. Aletti, B. Imbimbo, B. A. Canesi, M. Cutolo, S. Accardo, P. Castellani, L. Borsi, M. Cimmino, L. Zardi, P. Scagliusi, V. Fasiello, M. De Lucia, P. Loizzi, V. Pipitone, D. Ribatti, R. Contino, F. Di Pietro, R. Scarano, A. Tursi, P. Le Goff, B. Coutois, P. M. Lydyard, B. Le Poivre, A. Brousse, A. Rossi, M. Bini, R. Arcidiacono, B. Canesi, G. Casadei, M. Barberis, G. Rovetta Buffrini, F. Nicolini, L. Zakraoui, L. Daly, N. Daouissi, S. Haddad, G. La Montagna, M. Gallo, G. Squame, A. Giordano, G. Quattrocchi, A. Molica, E. Grasso, A. Lagana, R. Sirna, J. Olivieri, G. Rizzo, A. Porciatti, A. Italia, M. Capone, L. Zorbin, G. Cherie-Ligniere, A. Marconi, P. Coche, A. Riccio, F. De Marco, C. Farinaro, T. Prantera, S. Ferri, A. S. Villeco, M. Giacovazzo, A. Romiti, P. Martelletti, M. F. Gallo, R. Casale, P. Sessarego, A. Kokodoko, G. Dato, M. A. Cimmino, G. Bianchi, S. Mancinelli, M. C. Marazzi, L. Palombi, P. Concerva, L. Fiore, V. Biaccarini, A. Pana, C. Venegoni, M. Chevallard, M. Carrabba, E. Paresce, M. Anelini, M. Viara, L. Galcagno, P. Mercier, D. Fasciolo, M. L. Maglio, P. Carrara, B. Seriolo, A. Ferretti, A. Giglio, M. Vinci, T. Raciti, A. Gatto, F. DiStefano, A. Carcassi, S. Boschi, S. Campagna, G. Quattrohi, C. Musolino, E. Aliquo, F. Di Stefano, F. Crovato, G. Nazzari, J. P. Herne, J. Cledes, M. P. Guillodo, P. Le Guy, B. Bourbigot, R. Riccio, L. Farinaro, A. Scognamiglio, L. Lanteri, A. Percivalle, P. Maccagolo, G. Soave, E. Samanta, L. Zorzin, and T. Biagiotti
- Subjects
Mediterranean climate ,medicine.medical_specialty ,Rheumatology ,business.industry ,Family medicine ,Internal medicine ,Medicine ,General Medicine ,business - Published
- 1985
5. [Pilot study on the use of captopril in treatment of refractory rheumatoid arthritis]
- Author
-
M, Chevallard, C, Venegoni, D, Scaramuzza, M, Carrabba, and B, Colombo
- Subjects
Adult ,Arthritis, Rheumatoid ,Male ,Chemistry ,Captopril ,Chemical Phenomena ,Drug Evaluation ,Humans ,Female ,Pilot Projects ,Middle Aged ,Drug Administration Schedule - Published
- 1988
6. Gold nephropathy and renal amyloidosis in a patient with rheumatoid arthritis
- Author
-
M, Chevallard, M, Carrabba, C, Venegoni, E, Imbasciati, G, Banfi, and M J, Mihatsch
- Subjects
Arthritis, Rheumatoid ,Azathioprine ,Humans ,Female ,Kidney Diseases ,Amyloidosis ,Gold ,Methylprednisolone ,Aged - Abstract
A 71-year-old Caucasian woman with rheumatoid arthritis, who had been treated with gold salts for 19 months, developed a significant proteinuria associated with nephrotic syndrome and renal impairment. Her renal biopsy revealed the unusual simultaneous occurrence of gold nephropathy and renal amyloidosis and she was treated by gold withdrawal, methylprednisolone pulses and azathioprine, with a good remission of symptoms. We describe the case and discuss the possible cause(s) of similar renal involvement and the results obtained with the combined therapy of steroids and cytotoxic drugs.
- Published
- 1985
7. Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer.
- Author
-
Armanetti P, Locatelli I, Venegoni C, Alchera E, Campanella B, Pederzoli F, Maturi M, Locatelli E, Tortorella S, Curnis F, Corti A, Lucianò R, Onor M, Salonia A, Montorsi F, Moschini M, Popov V, Jose J, Comes Franchini M, Ooi EH, Menichetti L, and Alfano M
- Subjects
- Humans, Animals, Mice, Neoplasm, Residual, Cell Line, Tumor, Female, Photoacoustic Techniques methods, Urinary Bladder Neoplasms therapy, Urinary Bladder Neoplasms diagnostic imaging, Urinary Bladder Neoplasms pathology, Gold chemistry, Nanotubes chemistry, Theranostic Nanomedicine methods
- Abstract
Residual nonvisible bladder cancer after proper treatment caused by technological and therapeutic limitations is responsible for tumor relapse and progression. This study aimed to demonstrate the feasibility of a solution for simultaneous detection and treatment of bladder cancer lesions smaller than one millimeter. The α5β1 integrin was identified as a specific marker in 81% of human high-grade nonmuscle invasive bladder cancers and used as a target for the delivery of targeted gold nanorods (GNRs). In a preclinical model of orthotopic bladder cancer expressing the α5β1 integrin, the photoacoustic imaging of targeted GNRs visualized lesions smaller than one millimeter, and their irradiation with continuous laser was used to induce GNR-assisted hyperthermia. Necrosis of the tumor mass, improved survival, and computational modeling were applied to demonstrate the efficacy and safety of this solution. Our study highlights the potential of the GNR-assisted theranostic strategy as a complementary solution in clinical practice to reduce the risk of nonvisible residual bladder cancer after current treatment. Further validation through clinical studies will support the findings of the present study., Competing Interests: Competing interests statement:F.C., A.C., M.A., I.L., E.A., M. Maturi, E.L., and M.C.F. are inventors of patents regarding GNRs functionalized with peptide Iso4.
- Published
- 2024
- Full Text
- View/download PDF
8. Contrast enhanced photoacoustic detection of fibrillar collagen in the near infrared region-I.
- Author
-
Solomonov I, Locatelli I, Tortorella S, Unni M, Aharoni SL, Alchera E, Locatelli E, Maturi M, Venegoni C, Lucianò R, Salonia A, Corti A, Curnis F, Grasso V, Malamal G, Jose J, Comes Franchini M, Sagi I, and Alfano M
- Abstract
Fibrillar collagen accumulation emerges as a promising biomarker in several diseases, such as desmoplastic tumors and unstable atherosclerotic plaque. Gold nanorods (GNRs) hold great potential as contrast agents in high-resolution, biomedically safe, and non-invasive photoacoustic imaging (PAI). This study presents the design and characterization of a specialized imaging tool which exploits GNR assisted targeted photoacoustic imaging that is tailored for the identification of fibrillar collagen. In addition to the photoacoustic characterization of collagen in the NIR 1 and 2 regions, we demonstrate the detailed steps of conjugating a decoy to GNRs. This study serves as a proof of concept, that demonstrates that conjugated collagenase-1 (MMP-1) generates a distinct and collagen-specific photoacoustic signal, facilitating real-time visualization in the wavelength range of 700-970 nm (NIR I). As most of the reported studies utilized the endogenous contrast of collagen in the NIR II wavelength that has major limitations to perform in vivo deep tissue imaging, the approach that we are proposing is unique and it highlights the promise of MMP-1 decoy-functionalized GNRs as novel contrast agents for photoacoustic imaging of collagen in the NIR 1 region. To our knowledge this is the first time functionalized GNRs are optimized for the detection of fibrillar collagen and utilized in the field of non-invasive photoacoustic imaging that can facilitate a better prognosis of desmoplastic tumors and broken atherosclerotic plaques., Competing Interests: The authors declare no competing financial interests; GM and JJ are employees of FujiFilm VisualSonics., (This journal is © The Royal Society of Chemistry.)
- Published
- 2024
- Full Text
- View/download PDF
9. Topographic modification of the extracellular matrix precedes the onset of bladder cancer.
- Author
-
Venegoni C, Pederzoli F, Locatelli I, Alchera E, Martinez-Vidal L, Di Coste A, Bandini M, Necchi A, Montorsi F, Salonia A, Moschini M, Jose J, Scarfò F, Lucianò R, and Alfano M
- Abstract
Background: Non-muscle invasive bladder cancer (NMIBC) patients are affected by a high risk of recurrence. The topography of collagen fibers represents a hallmark of the neoplastic extracellular microenvironment., Objective: Assess the topographic change associated with different stages of bladder cancer (from neoplastic lesions to bona fide tumor) and whether those changes favour the development of NMIBC., Design Setting and Participants: Seventy-one clinical samples of urothelial carcinoma at different stages were used. Topographic changes preceding tumor onset and progression were evaluated in the rat bladder cancer model induced by nitrosamine (BBN), a bladder-specific carcinogen. The preclinical model of actinic cystitis was also used in combination with BBN. Validated hematoxylin-eosin sections were used to assess the topography of collagen fibrils associated with pre-tumoral steps, NMIBC, and MIBC., Findings: Linearization of collagen fibers was higher in Cis and Ta vs. dysplastic urothelium, further increased in T1 and greatest in T2 tumors. In the BBN preclinical model, an increase in the linearization of collagen fibers was established since the beginning of inflammation, such as the onset of atypia of a non-univocal nature and dysplasia, and further increased in the presence of the tumor. Linearization of collagen fibers in the model of actinic cystitis was associated with earlier onset of BBN-induced tumor., Conclusions: The topographic modification of the extracellular microenvironment occurs during the inflammatory processes preceding and favoring the onset of bladder cancer. The topographic reconfiguration of the stroma could represent a marker for identifying and treating the non-neoplastic tissue susceptible to tumor recurrence., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
10. Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer.
- Author
-
Pederzoli F, Riba M, Venegoni C, Marandino L, Bandini M, Alchera E, Locatelli I, Raggi D, Giannatempo P, Provero P, Lazarevic D, Moschini M, Lucianò R, Gallina A, Briganti A, Montorsi F, Salonia A, Necchi A, and Alfano M
- Subjects
- Animals, Humans, Muscles pathology, Neoadjuvant Therapy, Urinary Bladder Neoplasms pathology, Ruminococcus, Antibodies, Monoclonal, Humanized
- Abstract
Neoadjuvant pembrolizumab has been shown to be a valid treatment for patients affected by muscle-invasive bladder cancer (MIBC), as demonstrated in the PURE-01 clinical trial (NCT02736266). Among the tumor-extrinsic factors influencing immunotherapy efficacy, extensive data highlighted that the microbiome is a central player in immune-mediated anticancer activity. This report aimed to investigate the composition and role of stool microbiome in patients enrolled in the PURE-01 clinical trial. An orthotopic animal model of bladder cancer (MB49-Luc) was used to support some of the findings from human data. An analysis of stool microbiome before pembrolizumab was conducted for 42 patients, of whom 23 showed a pathologic response. The information in the preclinical model of orthotopic bladder cancer treated with anti-PD-1 antibody or control isotype was validated. Linear discriminant analysis effect size and linear models were used to identify the bacterial taxa enriched in either responders or nonresponders. The identified taxa were also tested for their association with event-free survival (EFS). Survival at 31 d after tumor instillation was used as the study endpoint in the preclinical model. Responders and nonresponders emerged to differ in terms of enrichment for 16 bacterial taxa. Of these, the genus Sutterella was enriched in responders, while the species Ruminococcus bromii was enriched in nonresponders. The negative impact of R. bromii on anti-PD-1 antibody activity was also observed in the preclinical model. EFS and survival of the preclinical model showed a negative role of R. bromii. We found different stool bacterial taxa associated with the response or lack of response to neoadjuvant pembrolizumab. Moreover, we provided experimental data about the negative role of R. bromii on immunotherapy response. Further studies are needed to externally validate our findings and provide mechanistic insights about the host-pathogen interactions in MIBC. PATIENT SUMMARY: Using prepembrolizumab stool samples collected from patients enrolled in the PURE-01 clinical trials, we identified some bacterial taxa that were enriched in patients who either responded or did not respond to immunotherapy. Using an animal model of bladder cancer, we gathered further evidence of the negative impact of the Ruminococcus bromii on immunotherapy efficacy. Further studies are needed to confirm the current findings and test the utility of these bacteria as predictive markers of immunotherapy response., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
- Author
-
Raineri D, Abreu H, Vilardo B, Kustrimovic N, Venegoni C, Cappellano G, and Chiocchetti A
- Subjects
- Mice, Animals, Mice, Knockout, Flow Cytometry, Inducible T-Cell Co-Stimulator Ligand genetics, Ligands, Mice, Inbred C57BL, T-Lymphocytes, Inducible T-Cell Co-Stimulator Protein metabolism, Encephalomyelitis, Autoimmune, Experimental metabolism
- Abstract
The inducible T cell co-stimulator ligand (ICOSL), expressed by antigen presenting cells, binds to the inducible T cell co-stimulator (ICOS) on activated T cells. Improper function of the ICOS/ICOSL pathway has been implicated in several autoimmune diseases, including multiple sclerosis (MS). Previous studies showed that ICOS-knockout (KO) mice exhibit severe experimental autoimmune encephalomyelitis (EAE), the animal model of MS, but data on ICOSL deficiency are not available. In our study, we explored the impact of both ICOS and ICOSL deficiencies on MOG
35-55 -induced EAE and its associated immune cell dynamics by employing ICOSL-KO and ICOS-KO mice with a C57BL/6J background. During EAE resolution, MOG-driven cytokine levels and the immunophenotype of splenocytes were evaluated by ELISA and multiparametric flow cytometry, respectively. We found that both KO mice exhibited an overlapping and more severe EAE compared to C57BL/6J mice, corroborated by a reduction in memory/regulatory T cell subsets and interleukin (IL-)17 levels. It is noteworthy that an unsupervised analysis showed that ICOSL deficiency modifies the immune response in an original way, by affecting T central and effector memory (TCM, TEM ), long-lived CD4+ TEM cells, and macrophages, compared to ICOS-KO and C57BL/6J mice, suggesting a role for other binding partners to ICOSL in EAE development, which deserves further study.- Published
- 2024
- Full Text
- View/download PDF
12. Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy.
- Author
-
Martinez-Vidal L, Testi C, Pontecorvo E, Pederzoli F, Alchera E, Locatelli I, Venegoni C, Spinelli A, Lucianò R, Salonia A, Podestà A, Ruocco G, and Alfano M
- Subjects
- Mice, Animals, Urinary Bladder diagnostic imaging, Elasticity, Fibrosis, Microscopy, Cystitis diagnostic imaging
- Abstract
Bladder mechanical properties are critical for organ function and tissue homeostasis. Therefore, alterations of tissue mechanics are linked to disease onset and progression. This study aims to characterize the tissue elasticity of the murine bladder wall considering its different anatomical components, both in healthy conditions and in actinic cystitis, a state characterized by tissue fibrosis. Here, we exploit Brillouin microscopy, an emerging technique in the mechanobiology field that allows mapping tissue mechanics at the microscale, in non-contact mode and free of labeling. We show that Brillouin imaging of bladder tissues is able to recognize the different anatomical components of the bladder wall, confirmed by histopathological analysis, showing different tissue mechanical properties of the physiological bladder, as well as a significant alteration in the presence of tissue fibrosis. Our results point out the potential use of Brillouin imaging on clinically relevant samples as a complementary technique to histopathological analysis, deciphering complex mechanical alteration of each tissue layer of an organ that strongly relies on mechanical properties to perform its function., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
13. A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods.
- Author
-
Alfano M, Alchera E, Sacchi A, Gori A, Quilici G, Locatelli I, Venegoni C, Lucianò R, Gasparri AM, Colombo B, Taiè G, Jose J, Armanetti P, Menichetti L, Musco G, Salonia A, Corti A, and Curnis F
- Subjects
- Animals, Mice, Contrast Media, Integrin alpha5beta1, Gold, Photoacoustic Techniques, Urinary Bladder Neoplasms diagnostic imaging, Nanotubes
- Abstract
Background: Early detection and removal of bladder cancer in patients is crucial to prevent tumor recurrence and progression. Because current imaging techniques may fail to detect small lesions of in situ carcinomas, patients with bladder cancer often relapse after initial diagnosis, thereby requiring frequent follow-up and treatments., Results: In an attempt to obtain a sensitive and high-resolution imaging modality for bladder cancer, we have developed a photoacoustic imaging approach based on the use of PEGylated gold nanorods (GNRs) as a contrast agent, functionalized with the peptide cyclic [CphgisoDGRG] (Iso4), a selective ligand of α5β1 integrin expressed by bladder cancer cells. This product (called GNRs@PEG-Iso4) was produced by a simple two-step procedure based on GNRs activation with lipoic acid-polyethyleneglycol(PEG-5KDa)-maleimide and functionalization with peptide Iso4. Biochemical and biological studies showed that GNRs@PEG-Iso4 can efficiently recognize purified integrin α5β1 and α5β1-positive bladder cancer cells. GNRs@PEG-Iso4 was stable and did not aggregate in urine or in 5% sodium chloride, or after freeze/thaw cycles or prolonged exposure to 55 °C, and, even more importantly, do not settle after instillation into the bladder. Intravesical instillation of GNRs@PEG-Iso4 into mice bearing orthotopic MB49-Luc bladder tumors, followed by photoacoustic imaging, efficiently detected small cancer lesions. The binding to tumor lesions was competed by a neutralizing anti-α5β1 integrin antibody; furthermore, no binding was observed to healthy bladders (α5β1-negative), pointing to a specific targeting mechanism., Conclusion: GNRs@PEG-Iso4 represents a simple and robust contrast agent for photoacoustic imaging and diagnosis of small bladder cancer lesions., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
14. Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques.
- Author
-
Bettio V, Mazzucco E, Antona A, Cracas S, Varalda M, Venetucci J, Bruno S, Chiabotto G, Venegoni C, Vasile A, Chiocchetti A, Quaglia M, Camussi G, Cantaluppi V, Panella M, Rolla R, Manfredi M, and Capello D
- Subjects
- Humans, Plasma metabolism, Biomarkers metabolism, Blotting, Western, Anticoagulants pharmacology, Anticoagulants metabolism, Extracellular Vesicles metabolism
- Abstract
Extracellular vesicles (EVs) isolated from plasma are increasingly recognized as promising circulating biomarkers for disease discovery and progression, as well as for therapeutic drug delivery. The scientific community underlined the necessity of standard operative procedures for the isolation and storage of the EVs to ensure robust results. The understanding of the impact of the pre-analytical variables is still limited and some considerations about plasma anticoagulants and isolation methods are necessary. Therefore, we performed a comparison study between EVs isolated by ultracentrifugation and by affinity substrate separation from plasma EDTA and sodium citrate. The EVs were characterized by Nano Tracking Analysis, Western Blot, cytofluorimetric analysis of surface markers, and lipidomic analysis. While anticoagulants did not significantly alter any of the analyzed parameters, the isolation methods influenced EVs size, purity, surface markers expression and lipidomic profile. Compared to ultracentrifugation, affinity substrate separation yielded bigger particles highly enriched in tetraspanins (CD9, CD63, CD81), fatty acids and glycerolipids, with a predominant LDL- and vLDL-like contamination. Herein, we highlighted that the isolation method should be carefully evaluated prior to study design and the need of standardized operative procedures for EVs isolation and application to biomarkers discovery., Competing Interests: Prof. Giovanni Camussi actually serves as a member of the Editorial Board of PLOS ONE. This does not alter our adherence to PLOS ONE policies on sharing data and materials., (Copyright: © 2023 Bettio et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
15. Age Estimation in 0-8-Year-Old Children in France: Comparison of One Skeletal and Five Dental Methods.
- Author
-
Martrille L, Papadodima S, Venegoni C, Molinari N, Gibelli D, Baccino E, and Cattaneo C
- Abstract
Age estimation in juveniles is a critical procedure in judicial cases for verification of imputability or for civil reasons when adopting children. Several methods based both on skeletal and dental growth have been performed and applied on different populations; nevertheless, few articles have compared different methods in order to test their reliability in different conditions and age ranges, and this is a clear obstacle in the creation of common guidelines for age estimation in the living. A comparison of five dental methods (Anderson, Ubelaker, Schour and Massler, Gustafson and Koch, Demirjian) and one skeletal method (Greulich a Pyle atlas) was performed on a population of 94 children aged between 0 and 8 years. Results showed that, whereas under 2 years all the methods have the same inaccuracy, over 2 years the diagram methods, such as Schour and Massler and Ubelaker's revised one, have a lower error range than the most frequently used Greulich and Pyle atlas and Demirjian method. Schour and Massler, Gustafson and Koch, and Ubelaker methods showed, respectively, a mean error amounting to 0.40, 0.53, and 0.56 years versus the 0.74 and 0.88 years given by Demirjian and the Greulich and Pyle atlas. An in-depth analysis of the potential of several methods is necessary in order to reach a higher adherence of age estimation with the complexity of growth dynamics.
- Published
- 2023
- Full Text
- View/download PDF
16. Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence.
- Author
-
Martinez-Vidal L, Chighizola M, Berardi M, Alchera E, Locatelli I, Pederzoli F, Venegoni C, Lucianò R, Milani P, Bielawski K, Salonia A, Podestà A, and Alfano M
- Subjects
- Rats, Animals, Urinary Bladder, Extracellular Matrix, Cystitis pathology, Urinary Bladder Neoplasms pathology
- Abstract
Tissue mechanics determines tissue homeostasis, disease development and progression. Bladder strongly relies on its mechanical properties to perform its physiological function, but these are poorly unveiled under normal and pathological conditions. Here we characterize the mechanical fingerprints at the micro-scale level of the three tissue layers which compose the healthy bladder wall, and identify modifications associated with the onset and progression of pathological conditions (i.e., actinic cystitis and bladder cancer). We use two indentation-based instruments (an Atomic Force Microscope and a nanoindenter) and compare the micromechanical maps with a comprehensive histological analysis. We find that the healthy bladder wall is a mechanically inhomogeneous tissue, with a gradient of increasing stiffness from the urothelium to the lamina propria, which gradually decreases when reaching the muscle outer layer. Stiffening in fibrotic tissues correlate with increased deposition of dense extracellular matrix in the lamina propria. An increase in tissue compliance is observed before the onset and invasion of the tumor. By providing high resolution micromechanical investigation of each tissue layer of the bladder, we depict the intrinsic mechanical heterogeneity of the layers of a healthy bladder as compared with the mechanical properties alterations associated with either actinic cystitis or bladder tumor., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
17. Worse Disease Prognosis Is Associated to an Increase of Platelet-Derived Extracellular Vesicles in Hospitalized SARS-CoV-2 Patients.
- Author
-
Raineri D, Venegoni C, Calella MG, Vaschetto R, Scotti L, Canciani E, Manfredi M, Gavelli F, Castello L, Chiocchetti A, and Cappellano G
- Subjects
- Blood Platelets, Humans, Prognosis, SARS-CoV-2, COVID-19, Extracellular Vesicles
- Abstract
Platelet-derived extracellular vesicles (PLT-EVs), the most abundant circulating EVs, have been found to be increased in several human diseases, including viral infections. Recently, we documented that PLT-EV counts are higher in SARS-CoV-2+ patients, enrolled during the first two waves of COVID-19, occurred in Italy last year, and we suggested PLT-EVs as a biomarker of SARS-CoV-2 infection. The present study is aimed at testing the ability of PLT-EV levels, measured at hospital admission and within one week of hospitalization, to predict patient's outcome. We applied an easy, fast, and reliable method, based on flow cytometry, for the detection of PLT-EVs in unmanipulated blood samples. In a cohort of SARS-CoV-2 patients, enrolled during the third wave of COVID-19 in Italy, we confirmed that PLT-EV counts are higher in comparison to healthy controls. Moreover, their number is not affected by prehospitalization treatment neither with heparin nor with steroids that are recommended by WHO guidelines. Noteworthy, we identified two pattern of patients, those who increased their PTL-EV level during first week and those reducing it. The former group representented more compromised patients, with higher 4C score, and unfavorable outcome. In conclusion, our new findings would suggest that a worse evolution of the disease is linked with increasing PLT-EV levels in the week after hospital admission., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2022 Davide Raineri et al.)
- Published
- 2022
- Full Text
- View/download PDF
18. Causal contributors to tissue stiffness and clinical relevance in urology.
- Author
-
Martinez-Vidal L, Murdica V, Venegoni C, Pederzoli F, Bandini M, Necchi A, Salonia A, and Alfano M
- Subjects
- Humans, Urology, Cell Differentiation, Extracellular Matrix physiology, Fibroblasts physiology
- Abstract
Mechanomedicine is an emerging field focused on characterizing mechanical changes in cells and tissues coupled with a specific disease. Understanding the mechanical cues that drive disease progression, and whether tissue stiffening can precede disease development, is crucial in order to define new mechanical biomarkers to improve and develop diagnostic and prognostic tools. Classically known stromal regulators, such as fibroblasts, and more recently acknowledged factors such as the microbiome and extracellular vesicles, play a crucial role in modifications to the stroma and extracellular matrix (ECM). These modifications ultimately lead to an alteration of the mechanical properties (stiffness) of the tissue, contributing to disease onset and progression. We describe here classic and emerging mediators of ECM remodeling, and discuss state-of-the-art studies characterizing mechanical fingerprints of urological diseases, showing a general trend between increased tissue stiffness and severity of disease. Finally, we point to the clinical potential of tissue stiffness as a diagnostic and prognostic factor in the urological field, as well as a possible target for new innovative drugs., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
19. [Efficacy of and tolerance to a new NSAID in the treatment of arthrosis: droxicam. Randomized study versus tenoxicam].
- Author
-
Chevallard M, Venegoni C, and Colombo B
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Piroxicam therapeutic use, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Osteoarthritis drug therapy, Piroxicam analogs & derivatives, Pyridines therapeutic use
- Abstract
A four-week open study was carried out to evaluate the efficacy and tolerability of droxicam, a new NSAID, in the treatment of painful osteoarthritis (OA). The results were compared with those obtained treating a similar group of patients with tenoxicam, at the same dosage of 20 mg/day, orally administered. The study showed that both drugs are effective in treating OA, with a mild predominance of droxicam in decreasing pain, functional limitation and chronic inability score. Tolerability was excellent or good in over 70% of patients and only one subject of each group was dropped out for severe side-effects. According to the Authors droxicam has shown to be an effective analgesic and anti-inflammatory agent as judged by its efficacy on pain relief and joint mobility in OA.
- Published
- 1993
20. [Pilot study on the use of captopril in treatment of refractory rheumatoid arthritis].
- Author
-
Chevallard M, Venegoni C, Scaramuzza D, Carrabba M, and Colombo B
- Subjects
- Adult, Captopril administration & dosage, Chemical Phenomena, Chemistry, Drug Administration Schedule, Drug Evaluation, Female, Humans, Male, Middle Aged, Pilot Projects, Arthritis, Rheumatoid drug therapy, Captopril therapeutic use
- Published
- 1988
21. The coexistence of rheumatoid arthritis and systemic lupus erythematosus.
- Author
-
Venegoni C, Chevallard M, Mele G, Banfi G, and Carrabba M
- Subjects
- Adult, Female, Humans, Lupus Nephritis complications, Lupus Nephritis pathology, Arthritis, Rheumatoid complications, Lupus Erythematosus, Systemic complications
- Abstract
A 29-year-old white female with longstanding classical rheumatoid arthritis (RA) developed clinical and serological manifestations of systemic lupus erythematosus (SLE) with prominent signs of diffuse proliferative lupus nephritis. She fulfilled the ARA criteria for the classification of SLE as well as the ARA criteria for classical RA. The concomitant presence of these two affections in the same patient is rare and the discriminating features suggest that this coexistence may be coincidental. With respect to treatment, our patient had good relief of symptoms by a combined administration of methylprednisolone pulses and cyclophosphamide.
- Published
- 1987
- Full Text
- View/download PDF
22. Gold nephropathy and renal amyloidosis in a patient with rheumatoid arthritis.
- Author
-
Chevallard M, Carrabba M, Venegoni C, Imbasciati E, Banfi G, and Mihatsch MJ
- Subjects
- Aged, Amyloidosis drug therapy, Amyloidosis pathology, Azathioprine therapeutic use, Female, Humans, Kidney Diseases drug therapy, Kidney Diseases pathology, Methylprednisolone therapeutic use, Amyloidosis chemically induced, Arthritis, Rheumatoid drug therapy, Gold adverse effects, Kidney Diseases chemically induced
- Abstract
A 71-year-old Caucasian woman with rheumatoid arthritis, who had been treated with gold salts for 19 months, developed a significant proteinuria associated with nephrotic syndrome and renal impairment. Her renal biopsy revealed the unusual simultaneous occurrence of gold nephropathy and renal amyloidosis and she was treated by gold withdrawal, methylprednisolone pulses and azathioprine, with a good remission of symptoms. We describe the case and discuss the possible cause(s) of similar renal involvement and the results obtained with the combined therapy of steroids and cytotoxic drugs.
- Published
- 1985
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.